July 14, 2020
396
12
3.03%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:41:45Now PlayingThis week we discuss recent research (and the accompanying Twitter thread) on the risk of COVID-19 among users of proton pump inhibitors (PPIs). We also hold a philosophical discussion on the research surrounding time to treatment initiation (TTI) in cancer medicine. We end the episode with an interview with Dr. Lynora Saxinger of the University of Alberta, Edmonton, a specialist in Infectious Diseases.
PPIs and risk of COVID-19: twitter.com/BrennanSpiegel/stat…1280527527325265920
Back us on Patreon! www.patreon.com/plenarysession
Vinay Prasad
HemeOnc Doctor & Associate Professor
Host of Plenary Session Podcast
Twitter @vprasadmdmph
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.